Literature DB >> 17919309

Non-neuronopathic Gaucher disease due to saposin C deficiency.

A Tylki-Szymańska1, B Czartoryska, M-T Vanier, B J M H Poorthuis, J A E Groener, A Ługowska, G Millat, A M Vaccaro, E Jurkiewicz.   

Abstract

Gaucher disease is generally caused by a deficiency of the lysosomal enzyme glucocerebrosidase. The degradation of glycosphingolipids requires also the participation of sphingolipid activator proteins. The prosaposin PSAP gene codes for a single protein which undergoes post-translational cleavage to yield four proteins named saposins A, B, C and D. Saposin (SAP-) C is required for glucosylceramide degradation, and its deficiency results in a variant form of Gaucher disease. In this report, we present clinical, biochemical, and molecular findings in a 36-year-old man and his 30-year-old sister with non-neuronopathic Gaucher disease due to SAP-C deficiency. Very high levels of chitotriosidase activity, chemokine CCL18, and increased concentration of glucosylceramide in plasma and normal beta-glucosidase activity in skin fibroblasts were observed in the patients. A molecular genetics study of the PSAP gene enabled the identification of one missense mutation, p.L349P, located in the SAP-C domain and another mutation, p.M1L, located in the initiation codon of the prosaposin precursor protein. The presented findings describe the first cases where the non-neuronopathic Gaucher disease has been definitely demonstrated to be a consequence of SAP-C deficiency. Three previously described cases in the literature displayed a Gaucher type 3 phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919309     DOI: 10.1111/j.1399-0004.2007.00899.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  25 in total

1.  Serum prosaposin levels are increased in patients with advanced prostate cancer.

Authors:  Shahriar Koochekpour; Siyi Hu; Cruz Vellasco-Gonzalez; Ruiz Bernardo; Gissu Azabdaftari; Guodong Zhu; Haiyen E Zhau; Leland W K Chung; Robert L Vessella
Journal:  Prostate       Date:  2011-05-31       Impact factor: 4.104

Review 2.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

Review 3.  Invertebrate models of lysosomal storage disease: what have we learned so far?

Authors:  Samantha Hindle; Sarita Hebbar; Sean T Sweeney
Journal:  Invert Neurosci       Date:  2011-10-25

4.  Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Authors:  Nick Dekker; Laura van Dussen; Carla E M Hollak; Herman Overkleeft; Saskia Scheij; Karen Ghauharali; Mariëlle J van Breemen; Maria J Ferraz; Johanna E M Groener; Mario Maas; Frits A Wijburg; Dave Speijer; Anna Tylki-Szymanska; Pramod K Mistry; Rolf G Boot; Johannes M Aerts
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

5.  Saposin C protects glucocerebrosidase against α-synuclein inhibition.

Authors:  Thai Leong Yap; James M Gruschus; Arash Velayati; Ellen Sidransky; Jennifer C Lee
Journal:  Biochemistry       Date:  2013-10-01       Impact factor: 3.162

6.  A mutation in SCARB2 is a modifier in Gaucher disease.

Authors:  Arash Velayati; John DePaolo; Nidhi Gupta; Jae H Choi; Nima Moaven; Wendy Westbroek; Ozlem Goker-Alpan; Ehud Goldin; Barbara K Stubblefield; Edwin Kolodny; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2011-09-15       Impact factor: 4.878

7.  Sequencing of the GBA coactivator, Saposin C, in Parkinson disease.

Authors:  Bouchra Ouled Amar Bencheikh; Etienne Leveille; Jennifer A Ruskey; Dan Spiegelman; Christopher Liong; Edward A Fon; Guy A Rouleau; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2018-07-02       Impact factor: 4.673

8.  Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.

Authors:  Siyi Hu; Nathalie Delorme; Zhenzhen Liu; Tao Liu; Cruz Velasco-Gonzalez; Jone Garai; Ashok Pullikuth; Shahriar Koochekpour
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

Review 9.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

10.  Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.

Authors:  Ying Sun; Huimin Ran; Matt Zamzow; Kazuyuki Kitatani; Matthew R Skelton; Michael T Williams; Charles V Vorhees; David P Witte; Yusuf A Hannun; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.